Nadine Schur

2.2k total citations · 1 hit paper
32 papers, 1.5k citations indexed

About

Nadine Schur is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and Parasitology. According to data from OpenAlex, Nadine Schur has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pediatrics, Perinatology and Child Health, 11 papers in Economics and Econometrics and 10 papers in Parasitology. Recurrent topics in Nadine Schur's work include Global Maternal and Child Health (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Parasites and Host Interactions (10 papers). Nadine Schur is often cited by papers focused on Global Maternal and Child Health (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Parasites and Host Interactions (10 papers). Nadine Schur collaborates with scholars based in Switzerland, United Kingdom and United States. Nadine Schur's co-authors include Jürg Utzinger, Louis-Albert Tchuem Tchuenté, Penelope Vounatsou, Amadou Garba, J. Russell Stothard, Daniel G. Colley, Bobbie Person, David Rollinson, Stefanie Knopp and Khalfan A. Mohammed and has published in prestigious journals such as PLoS ONE, Journal of Clinical Epidemiology and The Lancet Infectious Diseases.

In The Last Decade

Nadine Schur

32 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Time to set the agenda for schistosomiasis elimination

2012 471 citations David Rollinson, Stefanie Knopp et al. Acta Tropica profile →

Peers

Countries citing papers authored by Nadine Schur

Since Specialization

Citations

This map shows the geographic impact of Nadine Schur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadine Schur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadine Schur more than expected).

Fields of papers citing papers by Nadine Schur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadine Schur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadine Schur. The network helps show where Nadine Schur may publish in the future.

Co-authorship network of co-authors of Nadine Schur

This figure shows the co-authorship network connecting the top 25 collaborators of Nadine Schur. A scholar is included among the top collaborators of Nadine Schur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadine Schur. Nadine Schur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-effectiveness of pembrolizumab as an adjuvant treatment of renal cell carcinoma post-nephrectomy in Switzerland 2024 ·Journal of Medical Economics ·Nadine Schur, (unknown), (unknown), Ying Xiao, Judith E. Lupatsch	1
2	Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study 2022 ·PLoS ONE ·Paola Salari, Cian O’Mahony, Séverine Henrard, Paco M J Welsing, Arjun Bhadhuri, Nadine Schur, Marie Roumet, Shanthi Beglinger, Thomas Beck, Katharina Tabea Jungo, Stephen Byrne, Stefanie Hossmann, Wilma Knol, Denis O’Mahony, Anne Spinewine, Nicolas Rodondi, Matthias Schwenkglenks	8
3	Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013–2019 2021 ·Swiss Medical Weekly ·Daphne Reinau, Nadine Schur, (unknown), Eva Blozik, (unknown), Andri Signorell, Matthias Schwenkglenks, Christoph Meier	5
4	Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation 2019 ·PLoS ONE ·Benjamin Speich, Nadine Schur, (unknown), Belinda von Niederhäusern, Lars G. Hemkens, Stefan Schandelmaier, Alain Amstutz, Benjamin Kasenda, Christiane Pauli‐Magnus, (unknown), Yuki Tomonaga, (unknown), Alain Nordmann, Erik von Elm, Matthias Briel, Matthias Schwenkglenks	9
5	Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland 2019 ·BMJ Open ·C. Simone Sutherland, Zanfina Ademi, (unknown), Nadine Schur, (unknown), Arjun Bhadhuri, Thierry D. Pache, Johannes Bitzer, Pierre Suchon, Valérie Albert, Kurt E. Hersberger, Goranka Tanačković, Matthias Schwenkglenks	2
6	Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data 2019 ·Swiss Medical Weekly ·(unknown), Daphne Reinau, Nadine Schur, Eva Blozik, (unknown), Andri Signorell, Christoph Meier, Matthias Schwenkglenks	23
7	Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data 2019 ·Vaccine ·(unknown), Daphne Reinau, Nadine Schur, Eva Blozik, (unknown), Andri Signorell, Ulrich Heininger, Matthias Schwenkglenks, Christoph Meier	14
8	A scoping review shows that several nonvalidated budget planning tools for randomized trials are available 2019 ·Journal of Clinical Epidemiology ·Benjamin Speich, Viktoria Gloy, Nadine Schur, Hannah Ewald, Lars G. Hemkens, Matthias Schwenkglenks, Matthias Briel	6
9	Prevalence and Associations of Psychological Distress, HIV Infection and HIV Care Service Utilization in East Zimbabwe 2017 ·AIDS and Behavior ·(unknown), Jeffrey W. Eaton, Albert Takaruza, Rebecca Rhead, Rufurwokuda Maswera, Nadine Schur, Lorraine Sherr, Constance Nyamukapa, Simon Gregson	13
10	Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data 2017 ·Journal of Clinical Epidemiology ·Benjamin Speich, Belinda von Niederhäusern, Nadine Schur, Lars G. Hemkens, Thomas Fürst, Neera Bhatnagar, Reem Alturki, Arnav Agarwal, Benjamin Kasenda, Christiane Pauli‐Magnus, Matthias Schwenkglenks, Matthias Briel	73
11	Spatial patterns of HIV prevalence and service use in East Zimbabwe: implications for future targeting of interventions 2017 ·Journal of the International AIDS Society ·Robin Schaefer, Simon Gregson, Albert Takaruza, Rebecca Rhead, (unknown), Nadine Schur, Sarah‐Jane Anderson, Constance Nyamukapa	21
12	Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list 2017 ·Journal of Clinical Epidemiology ·Benjamin Speich, Belinda von Niederhäusern, C Blum, Jennifer Keiser, Nadine Schur, Thomas Fürst, Benjamin Kasenda, Mirjam Christ‐Crain, Lars G. Hemkens, Christiane Pauli‐Magnus, Matthias Schwenkglenks, Matthias Briel	15
13	Rising Levels of HIV Infection in Older Adults in Eastern Zimbabwe 2016 ·PLoS ONE ·Joel Negin, Simon Gregson, Jeffrey W. Eaton, Nadine Schur, Albert Takaruza, Peter Mason, Constance Nyamukapa	24
14	Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis 2015 ·The Lancet Infectious Diseases ·Ying‐Si Lai, Patricia Biedermann, Uwem Friday Ekpo, Amadou Garba, Els Mathieu, Nicholas Midzi, Pauline N. M. Mwinzi, Eliézer K. N’Goran, Giovanna Raso, Rufin K. Assaré, Moussa Sacko, Nadine Schur, I. Talla, Louis-Albert Tchuem Tchuenté, Seydou Touré, Mirko S. Winkler, Jürg Utzinger, Penelope Vounatsou	185
15	Mapping and prediction of schistosomiasis in Nigeria using compiled survey data and Bayesian geospatial modelling 2013 ·Geospatial health ·Uwem Friday Ekpo, Eveline Hürlimann, Nadine Schur, Akinola Stephen Oluwole, Eniola Michael Abe, (unknown), (unknown), Sunday Isiyaku, (unknown), (unknown), (unknown), E. I. Braide, Yisa Saka, C. F. Mafiana, Thomas K. Kristensen, Jürg Utzinger, Penelope Vounatsou	49
16	Time to set the agenda for schistosomiasis elimination breakdown → 2012 ·Acta Tropica ·David Rollinson, Stefanie Knopp, (unknown), J. Russell Stothard, Louis-Albert Tchuem Tchuenté, Amadou Garba, Khalfan A. Mohammed, Nadine Schur, Bobbie Person, Daniel G. Colley, Jürg Utzinger	471
17	Determining Treatment Needs at Different Spatial Scales Using Geostatistical Model-Based Risk Estimates of Schistosomiasis 2012 ·PLoS neglected tropical diseases ·Nadine Schur, Penelope Vounatsou, Jürg Utzinger	29
18	Modelling age-heterogeneous Schistosoma haematobium and S. mansoni survey data via alignment factors 2011 ·Parasites & Vectors ·Nadine Schur, Jürg Utzinger, Penelope Vounatsou	13
19	Spatially explicit Schistosoma infection risk in eastern Africa using Bayesian geostatistical modelling 2011 ·Acta Tropica ·Nadine Schur, Eveline Hürlimann, Anna‐Sofie Stensgaard, (unknown), (unknown), Christopher Simoonga, Narcis B. Kabatereine, Thomas K. Kristensen, Jürg Utzinger, Penelope Vounatsou	58
20	Modelling the geographical distribution of co‐infection risk from single‐disease surveys 2011 ·Statistics in Medicine ·Nadine Schur, Laura Gosoniu, Giovanna Raso, Jürg Utzinger, Penelope Vounatsou	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact